Page last updated: 2024-12-05

nitromethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nitromethane: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

nitromethane : A primary nitroalkane that is methane in which one of the hydrogens is replace by a nitro group. A polar solvent (b.p. 101 degreeC), it is an important starting material in organic synthesis. It is also used as a fuel for rockets and radio-controlled models. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6375
CHEMBL ID276924
CHEBI ID77701
MeSH IDM0052653

Synonyms (72)

Synonym
AKOS009031372
nitro-methane
ch2no2
inchi=1/ch3no2/c1-2(3)4/h1h
NCGC00091494-01
ai3-00111
nitrometan [polish]
einecs 200-876-6
ccris 1205
nsc 428
un1261
hsdb 106
wln: wn1
75-52-5
nitrometan
methane, nitro-
nsc-428
nitrocarbol
nitromethane
nsc428
nitromethane, puriss., absolute, over molecular sieve (h2o <=0.01%), >=98.5% (gc)
nitromethane [un1261] [flammable liquid]
nitromethane, reagent grade, 96%
CHEMBL276924
chebi:77701 ,
FT-0659976
N0239
N0019
N0209
A838443
NCGC00091494-02
C19275
NCGC00258376-01
tox21_200822
dtxcid40977
dtxsid2020977 ,
cas-75-52-5
unii-ru5wg8c3f4
ru5wg8c3f4 ,
ec 200-876-6
methane, nitro-,ion(1-) (8ci,9ci)
nitromethane [iarc]
nitromethane [usp-rs]
nitromethane [hsdb]
nitromethane [mi]
nitromethane [inci]
nitromethane, acs
nitro- methane
no2ch3
nitro methane
ch3no2
meno2
23717-53-5
un 1261
nitro fuel (salt/mix)
F1908-0092
BR1297
mfcd00007400
nitromethane, saj first grade, >=90.0%
nitromethane, acs reagent, >=95%
nitromethane, for hplc, >=96%
nitromethane, analytical standard
nitromethane, reagentplus(r), >=99.0%
nitromethane, hplc grade
nitromethane, 99.0%
Q407733
STL185630
nitrometane
nitromethane (15n)
nmt(fire protection guide to hazardous materials. 13 ed. quincy, ma: national fire protection association, 2002., p. 49-109)
nitromethane (iarc)
nitromethane (usp-rs)

Research Excerpts

Overview

Halonitromethanes (HNMs) are a class of nitrogenous disinfection by-products (N-DBPs) that have so far received little attention and focused largely on trichloronitrome. Nitromethane (CH3NO2) is an important organic chemical raw material with a wide variety of applications.

ExcerptReferenceRelevance
"Nitromethane is a known toxicant and suspected human carcinogen. "( Nitromethane Exposure from Tobacco Smoke and Diet in the U.S. Population: NHANES, 2007-2012.
Blount, BC; Capella, KM; De Jesús, VR; Espenship, MF; Geldner, NB; Rasio, JP; Reese, CM; Rey deCastro, B; Silva, LK; Smith, MM; Woodford, AM, 2019
)
3.4
"Nitromethane (CH3NO2) is an important organic chemical raw material with a wide variety of applications as well as one of the most common pollutants. "( Highly sensitive amperometric biosensor based on electrochemically-reduced graphene oxide-chitosan/hemoglobin nanocomposite for nitromethane determination.
Wang, S; Wen, W; Wen, Y; Zhang, X, 2016
)
2.08
"Halonitromethanes (HNMs) are a class of nitrogenous disinfection by-products (N-DBPs) that have so far received little attention and focused largely on trichloronitromethane. "( Solvent-minimized extraction for determining halonitromethanes and trihalomethanes in water.
Gallego, M; Montesinos, I, 2012
)
1.19
"Halonitromethanes (HNMs) are a recently identified class of disinfection by-products (DBPs) in drinking water. "( Mutagenicity in Salmonella of halonitromethanes: a recently recognized class of disinfection by-products in drinking water.
DeMarini, DM; Kundu, B; Matthews, PP; Richard, AM; Richardson, SD; Swartz, PD, 2004
)
1.16
"Bromonitromethane is an inefficient suicide substrate for glucose oxidase (in contrast to the case of CH(3)CCl=NO(2)(-) and D-amino acid oxidase) because, in the enzyme-substrate encounter step, the required ionization states of enzyme (EH(0)(+), pK(a) approximately 3.5) and substrate (CHBr=NO(2)(-), pK(a) approximately 8.3) cannot be highly populated simultaneously. "( Active site generation of a protonically unstable suicide substrate from a stable precursor: glucose oxidase and dibromonitromethane.
Bright, HJ; Porter, DJ; Voet, JG, 2000
)
1.03

Effects

Nitromethane has wide industrial and commercial application as a polar solvent for adhesives and acrylics as well as explosive fuel. It has been shown to interfere with the determination of serum creatinine through the Jaffe reaction.

ExcerptReferenceRelevance
"Nitromethane has been shown to interfere with the determination of serum creatinine through the Jaffe reaction."( Apparent elevated creatinine after ingestion of nitromethane: interference with the Jaffe reaction.
Killorn, E; Lim, RK; Rieder, M, 2011
)
1.35
"Nitromethane has wide industrial and commercial application as a polar solvent for adhesives and acrylics as well as explosive fuel. "( Occupational allergic contact dermatitis to nitromethane.
Fowler, JF; Webb, KG, 2002
)
2.02
"Nitromethane has several properties that make it an interesting solvent for capillary electrophoresis especially for lipophilic analytes that are not sufficiently soluble in water: freezing and boiling points are suitable for laboratory conditions, low viscosity leads to favourable electrophoretic mobilities, or an intermediate dielectric constant enables dissolution of electrolytes. "( Nitromethane as solvent in capillary electrophoresis.
Kenndler, E; Porras, SP; Rosés, M; Subirats, X, 2005
)
3.21

Actions

ExcerptReferenceRelevance
"Nitromethane can cause a false elevation of serum creatinine concentration as measured by the widely used Jaffe colorimetric method."( Creatinine elevation associated with nitromethane exposure: a marker of potential methanol toxicity.
Clark, RF; Cook, MD, 2007
)
1.33

Toxicity

ExcerptReferenceRelevance
" However, data on toxic effect from in vivo experiment is limited."( Comparative toxicity of chloro- and bromo-nitromethanes in mice based on a metabolomic method.
Wu, B; Xian, Q; Yin, J; Zhang, XX, 2017
)
0.72

Dosage Studied

ExcerptRelevanceReference
" The removal efficiency was affected by initial NDMA concentration; higher NDMA dosing required higher ozone utilization."( Reinvestigation on the ozonation of N-nitrosodimethylamine: Influencing factors and degradation mechanism.
Li, Y; Lv, J; Song, Y, 2013
)
0.39
" 1B is not appropriate, based on the fact that rat mammary and harderian tumors are likely not relevant to humans and lung and liver tumors reported in mice were equivocal in their dose-response and statistical significance."( Hazard characterization of carcinogenicity, mutagenicity, and reproductive toxicity for short chain primary nitroalkanes.
Garnick, L; Gillie, C; Kozal, J; Maier, A; Monnot, A; Quinn, J; Spencer, P, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
EC 4.3.1.3 (histidine ammonia-lyase) inhibitorAn EC 4.3.1.* (ammonia-lyase) inhibitor that interferes with the action of histidine ammonia-lyase (EC 4.3.1.3).
polar aprotic solventA solvent with a comparatively high relative permittivity (or dielectric constant), greater than ca. 15, and a sizable permanent dipole moment, that cannot donate suitably labile hydrogen atoms to form strong hydrogen bonds.
explosiveA substance capable of undergoing rapid and highly exothermic decomposition.
NMR chemical shift reference compoundAny compound that produces a peak used to reference an NMR spectrum during data pre-processing.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
primary nitroalkaneA nitroalkane in which the nitro group is attached to a terminal carbon. Major microspecies at pH 7.3.
volatile organic compoundAny organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
alkylnitronates degradation350

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thyroid stimulating hormone receptorHomo sapiens (human)Potency30.63790.001628.015177.1139AID1259385
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency48.55770.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (30)

Assay IDTitleYearJournalArticle
AID212400Toxicity determined using Tadpole Narcosis Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID736767Inhibition of Escherichia coli MetAP expressed in Escherichia coli BL21(lambdaDE3) using Met-AMC as substrate at 10 uM incubated for 30 mins prior to substrate addition measured for 15 mins fluorometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736763Inhibition of Dengue virus NS2B-NS3 protease expressed in Escherichia coli BL21(lambdaDE3) using Abz-NleKRRS-3-(NO2)Y as substrate at 50 uM incubated for 15 mins prior to substrate addition measured for 15 mins by fluorometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID343683Octanol-water partition coefficient, log P of the compound2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID736366Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 20 to 24 hrs by broth microdilution assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736771Inhibition of Escherichia coli MurA expressed in Escherichia coli BL21(lambdaDE3) using UNAG and PEP as substrate incubated for 10 mins prior to PEP addition measured after 60 mins by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736367Antibacterial activity against Escherichia coli ATCC 25922 after 20 to 24 hrs by broth microdilution assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736758Cytotoxicity against human A431 cells after 72 hrs by crystal violet staining method2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736381Half life of the compound in tris buffer at pH 7.82013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736770Inhibition of Escherichia coli MurA C115D mutant expressed in Escherichia coli BL21(lambdaDE3) using UNAG and PEP as substrate incubated for 10 mins prior to PEP addition measured after 60 mins by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID736757Cytotoxicity against human MeWo cells after 72 hrs by crystal violet staining method2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736756Cytotoxicity against human Calu6 cells after 72 hrs by crystal violet staining method2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736760Cytotoxicity against human HaCaT cells after 72 hrs by crystal violet staining method2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736755Cytotoxicity against human CaSki cells after 72 hrs by crystal violet staining method2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736765Inhibition of human MetAP2 expressed in Escherichia coli BL21(lambdaDE3) using Met-AMC as substrate at 10 uM incubated for 30 mins prior to substrate addition measured for 15 mins fluorometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID343684Alkane-water partition coefficient, log P of the compound2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID736759Cytotoxicity against human Flow 2002 cells after 72 hrs by crystal violet staining method2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736380Half life of the compound in citrate buffer at pH 62013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736375Induction of GSH-adduct formation in citrate buffer at100 uM by RP-LC/MS analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736374Induction of GSSG formation in citrate buffer at 100 uM by RP-LC/MS analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736768Inhibition of Staphylococcus aureus MurA2 expressed in Escherichia coli BL21(lambdaDE3) using UNAG and PEP as substrate incubated for 10 mins prior to PEP addition measured after 60 mins by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736764Inhibition of thrombin (unknown origin) expressed in Escherichia coli BL21(lambdaDE3) using Boc-Val-Pro-Arg-AMC as substrate at 25 uM incubated for 15 mins prior to substrate addition measured for 10 mins by fluorometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736762Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 after 20 to 24 hrs by broth microdilution assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736753Cytotoxicity against human SW707 cells after 72 hrs by crystal violet staining method2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736761Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 10442 after 20 to 24 hrs by broth microdilution assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736766Inhibition of human MetAP1 expressed in Escherichia coli BL21(lambdaDE3) using Met-AMC as substrate at 10 uM incubated for 30 mins prior to substrate addition measured for 15 mins fluorometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736754Cytotoxicity against human Capan1 cells after 72 hrs by crystal violet staining method2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID736769Inhibition of Pseudomonas aeruginosa MurA expressed in Escherichia coli BL21(lambdaDE3) using UNAG and PEP as substrate incubated for 10 mins prior to PEP addition measured after 60 mins by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (204)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (9.31)18.7374
1990's15 (7.35)18.2507
2000's66 (32.35)29.6817
2010's91 (44.61)24.3611
2020's13 (6.37)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.83 (24.57)
Research Supply Index5.33 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index143.82 (26.88)
Search Engine Supply Index2.74 (0.95)

This Compound (62.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.94%)6.00%
Case Studies22 (10.68%)4.05%
Observational0 (0.00%)0.25%
Other180 (87.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]